ABT vs CLOV
Abbott Laboratories (ABT) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ABT and CLOV stock pages for the full models.
Not investment advice.